Anti-G6PD antibody produced in rabbit

G6PD gene is mapped to human chromosome Xq28, and spans 16.2kb. Its deficiency is highly hetereogenous, with around 190 variants being reported.

Glucose-6-phosphate dehydrogenase (G6PD), a cytoplasmic enzyme, is expressed in all the tissues.

Glucose-6-phosphate dehydrogenase recombinant protein epitope signature tag (PrEST)

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies^® protocols and other useful information.

Anti-G6PD antibody is suitable for:

• chromatin immunoprecipitation (CHIP)
• immunofluorescence
• western blotting

Anti-G6PD antibody produced in rabbit, a Prestige Antibody, is developed and validated by the Human Protein Atlas (HPA) project . Each antibody is tested by immunohistochemistry against hundreds of normal and disease tissues. These images can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link.To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.

Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.
Immunocytochemistry (1 paper)

Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is recessively inherited predominantly in males. Its activity shows statistical significant correlation with total bilirubin blood levels. G6PD suppression may help in the treatment strategies for inhibiting tumor progression and acts as a novel anti-hepatocellular carcinoma (HCC) target. Its deficiency is a common inherited enzyme defect (a disorder associated with acute or chronic hemolytic anemia). G6PD enzyme is responsible for the oxidation of glucose-6-phosphate, and thus, confers protection against oxidative damage in erythrocytes.

Glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme of the pentose phosphate pathway (PPP), plays a major role in cells to resist oxidative stress. In humans, G6PD deficiency is the prevalent enzymopathy, which causes hemolytic anemia and newborn jaundice. G6PD is involved in the accumulation of reactive oxygen species (ROS). It is also involved in the progression of various cancer, including renal cell carcinoma (RCC).

Prestige Antibodies^® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies^® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:

• IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
• Protein array of 364 human recombinant protein fragments.

Corresponding Antigen APREST74032

Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.